Anahita Bhathena
AbbVie (United States)(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Glioma Diagnosis and Treatment, Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy(2015)177 cited
- → Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia(2018)144 cited
- → Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade(2020)125 cited
- → Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression(2008)100 cited
- → TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS(2004)97 cited
- → Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans(2005)75 cited
- → Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925(2009)66 cited
- → Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors(2017)66 cited
- → Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification(2016)61 cited
- → Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP(2018)52 cited